Cibc World Market Inc. raised its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 37.3% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 54,497 shares of the company’s stock after buying an additional 14,816 shares during the period. Cibc World Market Inc.’s holdings in Cardinal Health were worth $12,126,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CAH. BlackRock Inc. acquired a new stake in Cardinal Health in the 2nd quarter worth about $6,293,115,000. Wellington Management Group LLP grew its position in shares of Cardinal Health by 247.5% during the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after acquiring an additional 10,584,119 shares during the last quarter. Bank of America Corp DE purchased a new position in shares of Cardinal Health in the 2nd quarter valued at approximately $689,066,000. Legal & General Group Plc purchased a new stake in Cardinal Health in the 2nd quarter valued at approximately $438,870,000. Finally, Pacer Advisors Inc. lifted its position in shares of Cardinal Health by 14.7% during the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company’s stock valued at $330,728,000 after acquiring an additional 200,021 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.
Cardinal Health Price Performance
NYSE CAH opened at $272.49 on Friday. The firm has a market cap of $62.98 billion, a P/E ratio of 35.25, a P/E/G ratio of 2.13 and a beta of 0.53. The stock’s 50-day moving average is $247.18 and its 200-day moving average is $226.54. Cardinal Health, Inc. has a one year low of $180.45 and a one year high of $286.29.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.94 by $0.32. The business had revenue of $67.51 billion during the quarter, compared to the consensus estimate of $66.67 billion. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. Cardinal Health’s revenue was up 5.5% on a year-over-year basis. During the same period last year, the business posted $2.55 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 12.96 EPS for the current year.
Cardinal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Monday, January 4th. Cardinal Health’s payout ratio is currently 26.65%.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on CAH. UBS Group raised their price objective on Cardinal Health from $280.00 to $295.00 and gave the stock a “buy” rating in a report on Friday, October 16th. TD Cowen raised their price target on Cardinal Health from $280.00 to $304.00 and gave the stock a “buy” rating in a report on Monday, November 9th. Argus upped their price target on shares of Cardinal Health from $264.00 to $309.00 and gave the company a “buy” rating in a report on Thursday, November 12th. Evercore reiterated an “outperform” rating and issued a $270.00 target price on shares of Cardinal Health in a report on Wednesday, August 12th. Finally, JPMorgan Chase & Co. increased their price target on Cardinal Health from $260.00 to $286.00 and gave the company a “neutral” rating in a report on Tuesday, November 10th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $290.13.
View Our Latest Stock Analysis on CAH
Cardinal Health Company Profile
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
Featured Stories
- Five stocks we like better than Cardinal Health
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
